International Business Machines Corporation (IBM)


NYSE - NYSE Real Time Price. Currency in USD
157.02+1.35 (+0.87%)
At close: 4:02 PM EDT

156.99 -0.03 (-0.02%)
Pre-Market: 8:33 AM EDT

People also watch:
CSCOHPQORCLINTCWMT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open156.71
Prev Close155.67
Bid156.50 x 100
Ask157.06 x 200
Day's Range156.65 - 158.49
52wk Range116.90 - 165.00
1y Target EstN/A
Market Cap150.09B
P/E Ratio (ttm)12.77
Beta0.78
Volume2,430,428
Avg Vol (3m)3,231,766
Dividend & Yield5.60 (3.60%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire32 minutes ago

    IBM's Watson Helps Employees Tackle Cancer

    ARMONK, N.Y., Oct. 11, 2016 /PRNewswire/ -- IBM (NYSE: IBM) today announced that many IBM U.S. employees fighting cancer will be able to tap into Watson for insights into their cancer treatment as well as potential clinical trial options. Through a unique collaboration with Best Doctors, an expert clinical consultation provider, qualifying IBMers and their family members will have access to Watson's suite of oncology offerings for insights on cancer treatment options, when covered under IBM's U.S. medical plan. With the patient's permission, the Best Doctors team will collect medical records and feed relevant data into Watson.

  • Market Realist57 minutes ago

    Why IBM Acquired Promontory Financial Group

    According to IBM, with Promontory’s integration into Watson, Watson's capabilities will get a significant boost.

  • The Wall Street Journal1 hour ago

    [$$] IBM to Offer U.S. Employees Watson Software to Identify Cancer Treatments

    IBM says it will offer its Watson artificial intelligence software to its U.S. employees to help them identify appropriate cancer treatments and options for clinical trials.